126 related articles for article (PubMed ID: 8490180)
1. Establishment of a karyotypically normal cytotoxic leukemic T-cell line from a T-ALL sample engrafted in SCID mice.
Cesano A; O'Connor R; Nowell PC; Lange B; Clark SC; Santoli D
Blood; 1993 May; 81(10):2714-22. PubMed ID: 8490180
[TBL] [Abstract][Full Text] [Related]
2. Maturation of acute T-lymphoblastic leukemia cells after CD2 ligation and subsequent treatment with interleukin-2.
Mentz F; Ouaaz F; Michel A; Blanc C; Hervé P; Bismuth G; Debré P; Merle-Béral H; Mossalayi MD
Blood; 1994 Aug; 84(4):1182-92. PubMed ID: 7519476
[TBL] [Abstract][Full Text] [Related]
3. Two unique human leukemic T-cell lines endowed with a stable cytotoxic function and a different spectrum of target reactivity analysis and modulation of their lytic mechanisms.
Cesano A; Santoli D
In Vitro Cell Dev Biol; 1992; 28A(9-10):648-56. PubMed ID: 1429367
[TBL] [Abstract][Full Text] [Related]
4. Use of a lethally irradiated major histocompatibility complex nonrestricted cytotoxic T-cell line for effective purging of marrows containing lysis-sensitive or -resistant leukemic targets.
Cesano A; Pierson G; Visonneau S; Migliaccio AR; Santoli D
Blood; 1996 Jan; 87(1):393-403. PubMed ID: 8547668
[TBL] [Abstract][Full Text] [Related]
5. Expansion of Philadelphia chromosome-negative CD3(+)CD56(+) cytotoxic cells from chronic myeloid leukemia patients: in vitro and in vivo efficacy in severe combined immunodeficiency disease mice.
Hoyle C; Bangs CD; Chang P; Kamel O; Mehta B; Negrin RS
Blood; 1998 Nov; 92(9):3318-27. PubMed ID: 9787169
[TBL] [Abstract][Full Text] [Related]
6. Synergistic and antagonistic effects of IL-1 alpha and IL-4, respectively, on the IL-2-dependent growth of a T cell receptor-gamma delta+ human T leukemia cell line.
Santoli D; O'Connor R; Cesano A; Phillips P; Colt TL; Lange B; Clark SC; Rovera G
J Immunol; 1990 Jun; 144(12):4703-11. PubMed ID: 2351825
[TBL] [Abstract][Full Text] [Related]
7. Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity.
Schmidt-Wolf IG; Negrin RS; Kiem HP; Blume KG; Weissman IL
J Exp Med; 1991 Jul; 174(1):139-49. PubMed ID: 1711560
[TBL] [Abstract][Full Text] [Related]
8. Growth factor-dependent differentiation along the myeloid and lymphoid lineages in an immature acute T lymphocytic leukemia.
O'Connor R; Cesano A; Kreider BL; Lange B; Clark SC; Nowell PC; Finan J; Rovera G; Santoli D
J Immunol; 1990 Dec; 145(11):3779-87. PubMed ID: 2246514
[TBL] [Abstract][Full Text] [Related]
9. Growth factor requirements of childhood acute T-lymphoblastic leukemia: correlation between presence of chromosomal abnormalities and ability to grow permanently in vitro.
O'Connor R; Cesano A; Lange B; Finan J; Nowell PC; Clark SC; Raimondi SC; Rovera G; Santoli D
Blood; 1991 Apr; 77(7):1534-45. PubMed ID: 1706955
[TBL] [Abstract][Full Text] [Related]
10. Cellular and molecular mechanisms of activation of MHC nonrestricted cytotoxic cells by IL-12.
Cesano A; Visonneau S; Clark SC; Santoli D
J Immunol; 1993 Sep; 151(6):2943-57. PubMed ID: 8104216
[TBL] [Abstract][Full Text] [Related]
11. Inducible expression of granulocyte-macrophage colony-stimulating factor, tumor necrosis factor-alpha, and interferon-gamma in two human cytotoxic leukemic T-cell lines.
Cesano A; Santoli D
In Vitro Cell Dev Biol; 1992; 28A(9-10):657-62. PubMed ID: 1429368
[TBL] [Abstract][Full Text] [Related]
12. Lineage switch in childhood leukemia with monosomy 7 and reverse of lineage switch in severe combined immunodeficient mice.
Fujisaki H; Hara J; Takai K; Nakanishi K; Matsuda Y; Ohta H; Osugi Y; Tokimasa S; Taniike M; Hosoi G; Sako M; Okada S
Exp Hematol; 1999 May; 27(5):826-33. PubMed ID: 10340398
[TBL] [Abstract][Full Text] [Related]
13. Mature T-lineage leukemia with growth factor-induced multilineage differentiation.
Griesinger F; Arthur DC; Brunning R; Parkin JL; Ochoa AC; Miller WJ; Wilkowski CW; Greenberg JM; Hurvitz C; Kersey JH
J Exp Med; 1989 Mar; 169(3):1101-20. PubMed ID: 2538542
[TBL] [Abstract][Full Text] [Related]
14. Antigen-specific recognition of autologous leukemia cells and allogeneic class-I MHC antigens by IL-2-activated cytotoxic T cells from a patient with acute T-cell leukemia.
Fisch P; Weil-Hillman G; Uppenkamp M; Hank JA; Chen BP; Sosman JA; Bridges A; Colamonici OR; Sondel PM
Blood; 1989 Jul; 74(1):343-53. PubMed ID: 2546621
[TBL] [Abstract][Full Text] [Related]
15. CD2-CD48 interactions promote cytotoxic T lymphocyte induction and function: anti-CD2 and anti-CD48 antibodies impair cytokine synthesis, proliferation, target recognition/adhesion, and cytotoxicity.
Musgrave BL; Watson CL; Hoskin DW
J Interferon Cytokine Res; 2003 Feb; 23(2):67-81. PubMed ID: 12744772
[TBL] [Abstract][Full Text] [Related]
16. Evolution of a CD3+CD4+ alpha/beta T-cell receptor+ mature T-cell clone from CD3-CD7+ sorted human bone marrow cells.
Pohla H; Adibzadeh M; Bühring HJ; Siegels-Hübenthal P; Deikeler T; Owsianowsky M; Schenk A; Rehbein A; Schlotz E; Schaudt K
Dev Immunol; 1993; 3(3):197-210. PubMed ID: 7506598
[TBL] [Abstract][Full Text] [Related]
17. Lineage determination of CD7+ CD5- CD2- and CD7+ CD5+ CD2- lymphoblasts: studies on phenotype, genotype, and gene expression of myeloperoxidase, CD3 epsilon, and CD3 delta.
Yoneda N; Tatsumi E; Teshigawara K; Nagata S; Nagano T; Kishimoto Y; Kimura T; Yasunaga K; Yamaguchi N
Am J Hematol; 1994 Apr; 45(4):310-20. PubMed ID: 7513945
[TBL] [Abstract][Full Text] [Related]
18. Low molecular weight B-cell growth factor and recombinant interleukin-2 are together able to generate cytotoxic T lymphocytes with LAK activity from the bone marrow cells of children with acute lymphoblastic leukemia.
Zhou MX; Findley HW; Ragab AH
Blood; 1989 Sep; 74(4):1355-9. PubMed ID: 2788465
[TBL] [Abstract][Full Text] [Related]
19. Combination anti-CD2 and anti-CD3 monoclonal antibodies induce tolerance while altering interleukin-2, interleukin-4, tumor necrosis factor, and transforming growth factor-beta production.
Chavin KD; Qin L; Lin J; Woodward JE; Baliga P; Bromberg JS
Ann Surg; 1993 Oct; 218(4):492-501; discussion 501-3. PubMed ID: 8215640
[TBL] [Abstract][Full Text] [Related]
20. Human cytotoxic CD8+ T-lymphocyte clones engraft in severe combined immunodeficient (SCID) mice but show diminished function.
de Kroon JF; van Bergen CA; de Paus RA; Kluin-Nelemans HC; Willemze R; Falkenburg JH
J Immunother; 1997 Mar; 20(2):101-10. PubMed ID: 9087382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
